Clover Health Investments, Corp (CLOV)

Clover Health Investments, Corp's Q·Score is 5.3/10 (Bearish), reflecting its current fundamentals, analyst data, and valuation metrics. Clean balance sheet with low leverage (0.0× debt-to-equity). Key area to monitor: currently unprofitable (-4% margin). This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.

The consensus price target for CLOV is $2.82, based on ratings from 3 Wall Street analysts. This is 3.9% above the current price of $2.71. Price targets are forward-looking estimates and not guarantees of future performance.

Clover Health Investments, Corp (CLOV) scores in line with sector averages on valuation metrics. Its forward P/E ratio stands at 30.1×.

Clover Health Investments, Corp is scheduled to report earnings in 3 days, on May 6, 2026.

Clover Health Investments, Corp has a net profit margin of -4.4%, indicating the company is currently operating at a net loss. Its gross margin stands at 18.5%, reflecting a more cost-intensive business model.

Clover Health Investments, Corp is reporting strong year-over-year growth of 44.7%.

Clover Health Investments, Corp has a debt-to-equity ratio of 0.01×, reflecting a very low debt-to-equity ratio, signalling a conservatively financed balance sheet. Its current ratio is 1.47×, suggesting it should be monitored for near-term liquidity.